SCOTTSDALE, ARIZONA (March 21, 2013) – Healthcare Trust of America, Inc. (NYSE:HTA) (“HTA”) announced today that its operating partnership, Healthcare Trust of America Holdings, LP (the “Operating Partnership”), has priced $300 million aggregate principal amount of 3.70% senior unsecured notes due April 2023 (the “Notes”) at 99.186% of the principal amount.
The Operating Partnership intends to use the net proceeds from the offering of the Notes to repay its $125.5 million senior secured term loan, to repay borrowings under the senior unsecured revolving credit facility and for general corporate purposes, including, without limitation, working capital and investment in real estate.
The notes are being offered only to qualified institutional buyers under Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”) and to non-U.S. persons outside the United States under Regulation S under the Securities Act. The notes and related guarantees being offered will not be initially registered under the Securities Act or the securities laws of any other place and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws.
This announcement shall not constitute an offer to sell or the solicitation of an offer to buy the notes nor shall there be any sale of the notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This notice is being issued pursuant to Rule 135c of the Securities Act.
This press release contains certain forward-looking statements. Forward-looking statements are based on current expectations, plans, estimates, assumptions and beliefs, including expectations, plans, estimates, assumptions and beliefs about HTA, stockholder value and earnings growth. The forward-looking statements included in this press release are subject to numerous risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements. These forward looking statements include, without limitations, statements concerning the proposed offering and any other statement that may predict, forecast, indicated or imply any future results, performance or achievements, Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond HTA’s control. For information about the risks and uncertainties associated with HTAs business, please refer to HTA’s filings with the U.S. Securities and Exchange Commission.
Forward-looking statements speak only as of the date made. Except as otherwise required by the federal securities laws, HTA undertakes no obligation to update any forward-looking statements to reflect the events or circumstances arising after the date as of which they are made. As a result of these risks and uncertainties, readers are cautioned not to place undue reliance on the forward-looking statements included in this press release or that may be made elsewhere from time to time by, or on behalf of, HTA.